For research use only. Not for therapeutic Use.
Terbinafine-d3 hydrochloride (CAS: 1310012-15-7), a premium pharmaceutical research compound designed for advanced antifungal studies. As a deuterated analog of Terbinafine hydrochloride, it offers enhanced stability and improved pharmacokinetic properties. Terbinafine-d3 hydrochloride is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel antifungal therapies. Trusted by leading laboratories, Terbinafine-d3 hydrochloride is your go-to solution for cutting-edge antifungal research. Unlock new possibilities in infection treatment with Terbinafine-d3 hydrochloride, where innovation meets reliability.
| Catalog Number | S000209 |
| CAS Number | 1310012-15-7 |
| Molecular Formula | C21H23D3ClN |
| Purity | ≥95% |
| IUPAC Name | (E)-6,6-dimethyl-N-(naphthalen-1-ylmethyl)-N-(trideuteriomethyl)hept-2-en-4-yn-1-amine;hydrochloride |
| InChI | InChI=1S/C21H25N.ClH/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19;/h5-7,9-14H,16-17H2,1-4H3;1H/b9-5+;/i4D3; |
| InChIKey | BWMISRWJRUSYEX-YOVIYTQZSA-N |
| SMILES | [2H]C([2H])([2H])N(C/C=C/C#CC(C)(C)C)CC1=CC=CC2=CC=CC=C21.Cl |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Ryder NS, et al. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol. 1992 Feb;126 Suppl 39:2-8. [3]. Mieth H, et al. Preclinical evaluation of terbinafine in vivo. Clin Exp Dermatol. 1989 Mar;14(2):104-8. [4]. Ciftci E, et al. Mupirocin vs terbinafine in impetigo.Indian J Pediatr. 2002 Aug;69(8):679-82. |
